Views & Analysis Clinical trial summaries for lay people – unpicking the guid... Creating drug trial summaries that the public can understand.
Views & Analysis Clinical trial lay summaries: a clearer picture emerges EC wants pharma to make clinical trial results more patient-friendly.
Oncology Hernexeos and what’s next, with Vicky Brown At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
